Search research articles
Contact Us
Filters
Showing results (121-130 of 133) with videos related to
Page
of 14
Sort By:
Journal of Medicinal Chemistry
|
October 13, 2006
Structural basis for the structure-activity relationships of peroxisome proliferator-activated receptor agonists
Neeraj Mahindroo, Yi-Hui Peng, Chia-Hui Lin, et al.
Chemmedchem
|
August 25, 2010
Structural basis for the improved potency of peroxisome proliferator-activated receptor (PPAR) agonists
Yi-Hui Peng, Mohane Selvaraj Coumar, Jiun-Shyang Leou, et al.
Anticancer Research
|
January 4, 2012
A high-throughput cell-based screening for L858R/T790M mutant epidermal growth factor receptor inhibitors
Wen-Hsing Lin, Jen-Shin Song, Tzu-Wen Lien, et al.
Investigational New Drugs
|
October 5, 2010
Synthesis and biological evaluation of 2-amino-1-thiazolyl imidazoles as orally active anticancer agents
Wen-Tai Li, Der-Ren Hwang, Jen-Shin Song, et al.
Journal of Medicinal Chemistry
|
February 3, 2006
Indol-1-yl acetic acids as peroxisome proliferator-activated receptor agonists: design, synthesis, structural biology, and molecular docking studies
Neeraj Mahindroo, Chiung-Chiu Wang, Chun-Chen Liao, et al.
Analytical Biochemistry
|
March 25, 2008
A cell-based high-throughput screen for epidermal growth factor receptor pathway inhibitors
Wen-Hsing Lin, Jen-Shin Song, Teng-Yuan Chang, et al.
Journal of Medicinal Chemistry
|
April 28, 2006
Structure-based drug design of a novel family of PPARgamma partial agonists: virtual screening, X-ray crystallography, and in vitro/in vivo biological activities
I-Lin Lu, Chien-Fu Huang, Yi-Hui Peng, et al.
Journal of Medicinal Chemistry
|
March 24, 2009
Design and structural analysis of novel pharmacophores for potent and selective peroxisome proliferator-activated receptor gamma agonists
Chia-Hui Lin, Yi-Hui Peng, Mohane Selvaraj Coumar, et al.
Journal of Medicinal Chemistry
|
February 7, 2023
Development of Furanopyrimidine-Based Orally Active Third-Generation EGFR Inhibitors for the Treatment of Non-Small Cell Lung Cancer
Mu-Chun Li, Mohane Selvaraj Coumar, Shu-Yu Lin, et al.
Journal of Medicinal Chemistry
|
September 28, 2019
Discovery of a Furanopyrimidine-Based Epidermal Growth Factor Receptor Inhibitor (DBPR112) as a Clinical Candidate for the Treatment of Non-Small Cell Lung Cancer
Shu-Yu Lin, Yung Chang Hsu, Yi-Hui Peng, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 133) with videos related to
Sort By:
Page
of 14
Journal of Medicinal Chemistry
|
October 13, 2006
Structural basis for the structure-activity relationships of peroxisome proliferator-activated receptor agonists
Neeraj Mahindroo, Yi-Hui Peng, Chia-Hui Lin, et al.
Chemmedchem
|
August 25, 2010
Structural basis for the improved potency of peroxisome proliferator-activated receptor (PPAR) agonists
Yi-Hui Peng, Mohane Selvaraj Coumar, Jiun-Shyang Leou, et al.
Anticancer Research
|
January 4, 2012
A high-throughput cell-based screening for L858R/T790M mutant epidermal growth factor receptor inhibitors
Wen-Hsing Lin, Jen-Shin Song, Tzu-Wen Lien, et al.
Investigational New Drugs
|
October 5, 2010
Synthesis and biological evaluation of 2-amino-1-thiazolyl imidazoles as orally active anticancer agents
Wen-Tai Li, Der-Ren Hwang, Jen-Shin Song, et al.
Journal of Medicinal Chemistry
|
February 3, 2006
Indol-1-yl acetic acids as peroxisome proliferator-activated receptor agonists: design, synthesis, structural biology, and molecular docking studies
Neeraj Mahindroo, Chiung-Chiu Wang, Chun-Chen Liao, et al.
Analytical Biochemistry
|
March 25, 2008
A cell-based high-throughput screen for epidermal growth factor receptor pathway inhibitors
Wen-Hsing Lin, Jen-Shin Song, Teng-Yuan Chang, et al.
Journal of Medicinal Chemistry
|
April 28, 2006
Structure-based drug design of a novel family of PPARgamma partial agonists: virtual screening, X-ray crystallography, and in vitro/in vivo biological activities
I-Lin Lu, Chien-Fu Huang, Yi-Hui Peng, et al.
Journal of Medicinal Chemistry
|
March 24, 2009
Design and structural analysis of novel pharmacophores for potent and selective peroxisome proliferator-activated receptor gamma agonists
Chia-Hui Lin, Yi-Hui Peng, Mohane Selvaraj Coumar, et al.
Journal of Medicinal Chemistry
|
February 7, 2023
Development of Furanopyrimidine-Based Orally Active Third-Generation EGFR Inhibitors for the Treatment of Non-Small Cell Lung Cancer
Mu-Chun Li, Mohane Selvaraj Coumar, Shu-Yu Lin, et al.
Journal of Medicinal Chemistry
|
September 28, 2019
Discovery of a Furanopyrimidine-Based Epidermal Growth Factor Receptor Inhibitor (DBPR112) as a Clinical Candidate for the Treatment of Non-Small Cell Lung Cancer
Shu-Yu Lin, Yung Chang Hsu, Yi-Hui Peng, et al.
Page
of 14